Madrigal Pharmaceuticals IncNASDAQ:MDGL
- LAST PRICE282.7200
- TODAY'S CHANGE (%)-19.9500 (-6.5913%)
- Bid / Lots281.0000/ 7
- Ask / Lots282.6100/ 7
- Open / Previous Close303.2900 / 302.6700
- Day Range
- 52 Week Range
- Volume293,442
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MDGL |
|---|---|---|
| 09:32 ET | 8952 | 301.705 |
| 09:33 ET | 1125 | 294.52 |
| 09:35 ET | 1050 | 296.54 |
| 09:37 ET | 4597 | 293.8 |
| 09:39 ET | 2166 | 293.9 |
| 09:42 ET | 1070 | 290.86 |
| 09:44 ET | 5995 | 291.76 |
| 09:46 ET | 2530 | 291.52 |
| 09:48 ET | 908 | 290.625 |
| 09:50 ET | 524 | 290.3633 |
| 09:51 ET | 1982 | 289.26 |
| 09:53 ET | 4434 | 291.9 |
| 09:55 ET | 4941 | 287.8 |
| 09:57 ET | 2313 | 288 |
| 10:00 ET | 2383 | 287.53 |
| 10:02 ET | 8409 | 290.46 |
| 10:04 ET | 6744 | 289.78 |
| 10:06 ET | 2271 | 288.1401 |
| 10:08 ET | 1780 | 288.405 |
| 10:09 ET | 1000 | 286.34 |
| 10:11 ET | 1170 | 285.53 |
| 10:13 ET | 2789 | 286.705 |
| 10:15 ET | 3147 | 286.68 |
| 10:18 ET | 1650 | 286.96 |
| 10:20 ET | 740 | 285.6765 |
| 10:22 ET | 500 | 286.615 |
| 10:24 ET | 6827 | 285.815 |
| 10:26 ET | 2300 | 283.57 |
| 10:27 ET | 860 | 285.84 |
| 10:29 ET | 300 | 286.635 |
| 10:31 ET | 610 | 286.5 |
| 10:33 ET | 1700 | 285 |
| 10:36 ET | 100 | 284.73 |
| 10:38 ET | 1580 | 285.11 |
| 10:40 ET | 1200 | 285.14 |
| 10:42 ET | 900 | 284.045 |
| 10:44 ET | 3700 | 283 |
| 10:45 ET | 2047 | 283.36 |
| 10:47 ET | 2642 | 282.5 |
| 10:49 ET | 1600 | 284.62 |
| 10:51 ET | 600 | 284.825 |
| 10:54 ET | 1427 | 283.82 |
| 10:56 ET | 725 | 283.21 |
| 10:58 ET | 500 | 283 |
| 11:00 ET | 200 | 282.87 |
| 11:02 ET | 800 | 281.71 |
| 11:03 ET | 1813 | 283.47 |
| 11:05 ET | 425 | 281.88 |
| 11:07 ET | 1742 | 282.645 |
| 11:09 ET | 4698 | 282.64 |
| 11:12 ET | 262 | 281.99 |
| 11:14 ET | 1742 | 283.54 |
| 11:16 ET | 500 | 283.39 |
| 11:18 ET | 4850 | 285.79 |
| 11:20 ET | 986 | 286.07 |
| 11:21 ET | 6524 | 287.8323 |
| 11:23 ET | 2072 | 286.86 |
| 11:27 ET | 200 | 286.885 |
| 11:30 ET | 375 | 288.45 |
| 11:32 ET | 3037 | 287.255 |
| 11:34 ET | 3088 | 288.58 |
| 11:36 ET | 1800 | 288.58 |
| 11:38 ET | 3661 | 287.81 |
| 11:39 ET | 1756 | 287.085 |
| 11:41 ET | 1000 | 285.045 |
| 11:43 ET | 500 | 284.915 |
| 11:48 ET | 1450 | 284.16 |
| 11:50 ET | 1152 | 283.72 |
| 11:52 ET | 1640 | 283.835 |
| 11:54 ET | 4086 | 283.72 |
| 11:56 ET | 200 | 284.44 |
| 11:57 ET | 200 | 283.73 |
| 11:59 ET | 200 | 284.6 |
| 12:01 ET | 100 | 284.445 |
| 12:03 ET | 1300 | 283.24 |
| 12:06 ET | 2913 | 285.715 |
| 12:08 ET | 700 | 284.85 |
| 12:10 ET | 500 | 284.94 |
| 12:12 ET | 400 | 285.09 |
| 12:14 ET | 100 | 284.92 |
| 12:15 ET | 361 | 283.98 |
| 12:19 ET | 300 | 284.04 |
| 12:24 ET | 400 | 284.685 |
| 12:26 ET | 2737 | 284.71 |
| 12:30 ET | 300 | 284.53 |
| 12:32 ET | 1928 | 283.84 |
| 12:33 ET | 1800 | 285.47 |
| 12:35 ET | 200 | 284.21 |
| 12:37 ET | 390 | 285.4599 |
| 12:39 ET | 100 | 285.3 |
| 12:42 ET | 100 | 284.665 |
| 12:44 ET | 1400 | 282.82 |
| 12:46 ET | 700 | 283.51 |
| 12:48 ET | 500 | 282.46 |
| 12:50 ET | 1206 | 282.17 |
| 12:51 ET | 2293 | 282.49 |
| 12:53 ET | 800 | 282.98 |
| 12:55 ET | 370 | 282.72 |
Nov 6, 2024
Madrigal Pharmaceuticals, Inc. Announces Participation at Three Upcoming Investor Conferences, from 8:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
8:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
Nov 5, 2024
DJ Madrigal Pharmaceuticals Is Maintained at Neutral by B. Riley Securities, from 11:22AM ET on Tuesday Nov 05, 2024 by Dow Jones
11:22AM ET on Tuesday Nov 05, 2024 by Dow Jones
Nov 1, 2024
DJ Madrigal Pharmaceuticals Is Maintained at Buy by UBS, from 2:37PM ET on Friday Nov 01, 2024 by Dow Jones
2:37PM ET on Friday Nov 01, 2024 by Dow Jones
Oct 31, 2024
Madrigal Pharmaceuticals Reports Third-Quarter 2024 Financial Results and Provides Corporate Updates, from 7:01AM ET on Thursday Oct 31, 2024 by Dow Jones
7:01AM ET on Thursday Oct 31, 2024 by Dow Jones*DJ Madrigal Pharmaceuticals 3Q Loss/Shr $4.92 >MDGL, from 7:01AM ET on Thursday Oct 31, 2024 by Dow Jones
7:01AM ET on Thursday Oct 31, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Madrigal Pharmaceuticals Inc | 6.6B | -11.3x | --- |
Cytokinetics Inc | 6.4B | -9.5x | --- |
Viking Therapeutics Inc | 6.0B | -53.1x | --- |
Nuvalent Inc | 5.9B | -25.6x | --- |
Avidity Biosciences Inc | 5.9B | -15.2x | --- |
Crinetics Pharmaceuticals Inc | 5.3B | -14.9x | --- |
Company Information
Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH). The Company's product candidate, resmetirom, is a once-daily, oral, liver-directed thyroid hormone receptor-β (THR-β) agonist designed to target key underlying causes of NASH. NASH is a more advanced form of non-alcoholic fatty liver disease (NAFLD). The Company’s clinical development program includes MAESTRO-NASH, MAESTRO-NAFLD-1, and MAESTRO-NASH OUTCOMES.
Contact Information
- Headquarters
- 200 Barr Harbor Dr Ste 400WEST CONSHOHOCKEN, PA, United States 19428-2978
- Phone
- 404-380-9263
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Julian Baker
- President, Chief Executive Officer, Director
- Bill Sibold
- Chief Financial Officer, Senior Vice President
- Mardi Dier
- President of Research and Development, Chief Medical Officer, Director
- Rebecca Taub
- Senior Vice President - Clinical Development
- Michael Charlton
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $6.6B |
|---|---|
Revenue (TTM) | $76.8M |
Shares Outstanding | 21.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.47 |
EPS | $-25.07 |
Book Value | $20.39 |
P/E Ratio | -11.3x |
Price/Sales (TTM) | 85.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -713.49% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
